ZENTALIS PHARMACEUTICALS INC shareholders Q3 2023

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

ZENTALIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
Integral Health Asset Management, LLC 450,000$9,027,0001.25%
Cormorant Asset Management, LP 700,000$14,042,0000.82%
Ghost Tree Capital, LLC 100,000$2,006,0000.66%
Values First Advisors, Inc. 40,920$820,8520.53%
Boxer Capital, LLC 450,000$9,027,0000.48%
Regency Capital Management Inc.\DE 15,000$300,9000.26%
Woodline Partners LP 1,000,000$20,060,0000.24%
Verition Fund Management LLC 537,359$10,779,4220.13%
FEDERATED HERMES, INC. 1,947,693$39,070,7220.10%
KENNEDY CAPITAL MANAGEMENT LLC 156,475$3,138,8890.08%
External links

This page lists ZENTALIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view ZENTALIS PHARMACEUTICALS INC's shareholder history, click here.